The 3 Things That Matter for Vertex Pharmaceuticals Now

Vertex Pharmaceuticals (NASDAQ: VRTX) has been a terrific stock to own over the past decade. The stock has outperformed the market over this period, thanks to consistent financial results and excellent innovative capabilities. But how much longer can the biotech keep things up?If you're interested in owning the stock for the long term, it's important to pay close attention to several parts of the company's business. Below are three key things to watch out for now.Vertex is best known for its work in developing and marketing medicines that target cystic fibrosis (CF) at its genetic roots. CF is a rare disease affecting the lungs. Although many have attempted to challenge the biotech in this area, none have yet succeeded; Vertex's therapies remain the only option for CF patients.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool